Magnesium therapy in borderline hypertension

Trace Elements and Electrolytes

Volumn 29, Issue 2, 2012, Pages 113-116

  Kisters, Klaus ^a   Wessels, Franz ^a   Nguyen, Michael Q ^b   Mitchell, Anna ^b   Gremmler, Bernhard ^c   Funke, Christoph ^a   Baraliakos, Xenofon ^a   Kask, Bartholomäus ^a   Hausberg, Martin ^d   Hunger, Robert ^e   Liebscher, Dierck H ^f   Liebscher, Ursula ^f   Tokmak, Faruk ^b,g  

^a Medical Clinic I   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c Cardiology   (Germany)

^d Nephrology   (Germany)

^e KANTONSSPITAL GRAUBÜNDEN   (Switzerland)

^f Magnesiumhilfe   (Germany)

^g MVZ Dialyse   (Germany)

Author keywords

Borderline hypertension; Magnesium

Indexed keywords

MAGNESIUM ION;

ADULT; ARTICLE; BORDERLINE HYPERTENSION; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ERYTHROCYTE; FEMALE; HUMAN; MAGNESIUM BLOOD LEVEL; MAGNESIUM DEFICIENCY; MALE; PRIORITY JOURNAL; SPHYGMOMANOMETER; SUPPLEMENTATION; SYSTOLIC BLOOD PRESSURE;

EID: 84860770470     PISSN: 09462104     EISSN: None     Source Type: Journal    
DOI: 10.5414/TEX01201     Document Type: Article

References (26)

1. Jee SH, Miller ER III, Guallar E, Singh VK, Appel LJ, Klag MJ. The effect of magnesium supplementation on blood pressure: a meta-analysis of randomized clinical trials. Am J Hypertens. 2002; 15: 691-696. doi:10.1016/S0 895- 7061(02)02964-3 PubMed
2. Kisters K, Cziborra M, Funke C, Kozianka J, Nguyen MQ, Tokmak F, Krämer B, Gremmler B, Hausberg M, Micke O, Büntzel J, Mücke R, Liebscherz DH. Der Mgnesiumhaushalt in der Inneren und Intensivmedizin. Nieren- und Hochdruckkrankheiten. 2010; 5: 182-194.
3. Altura BM, Altura BT. Cardiovascular risk factors and magnesium: relationships to atherosclerosis, ischemic heart disease and hypertension. Magnes Trace Elem. 1991-1992; 10: 182-192. PubMed
4. Büntzel J, Kisters K, Micke O, Mücke R. Zytoprotektion, Spurenelemente und Elektrolyte in der Tumortherapie. München-Orlando. Dustri 2004.
5. Gröber U. Antihypertensives and magnesium - update 2007. Trace Elem Elec. 2009; 26: 15-16.
6. Itoh K, Kawasaka T, Nakamura M. The effects of high oral magnesium supplementation on blood pressure, serum lipids and related variables in apparently healthy Japanese subjects. Br J Nutr. 1997; 78: 737-750. doi:10.1079/BJN19970191 PubMed (Pubitemid 27483017)
7. Kisters K, Spieker C, Tepel M, Zidek W. New data about the effects of oral physiological magnesium supplementation on several cardiovascular risk factors (lipids and blood pressure). Magnes Res. 1993; 6: 355-360. PubMed
8. 2+ concentrations in a subgroup of hypertensives - cell models for the pathogenesis of primary hypertension. J Hum Hypertens. 1997; 11: 367-372. doi:10.1038/sj.jhh.1000447 PubMed
9. 2+ concentrations in a subgroup of hypertensives: membrane model for the pathogenesis of primary hypertension. Am J Hypertens. 1998; 11: 1390-1393. doi:10.1016/S0895-7061(98) 00169-1 PubMed
10. Kisters K. Disorders of magnesium balance. Internist (Berlin). 1998; 39: 815-819. doi:10.1007/s001080050249 PubMed
11. Kisters K, Schäfer R, Kosch M. Importance of an intact magnesium balance. Urologe A. 2000; 39: 64-70. PubMed doi:10.1007/s001200050012
12. Kisters K, Gremmler B, Hausberg M. Magnesium and arterial stiffness. Hypertension. 2006; 47: e3, author reply e3. doi:10.1161/01.hyp.000019 7263.07085.e8 PubMed
13. Kisters K, Hoffmann O, Hausberg M, Funke C, Kozianka J, Gremmler B. Magnesium und Pulsdruck bei Hypertonie. Nieren und Hochdruckkrkh. 2005; 34: 455-457. (Pubitemid 41578652)
14. Kisters K, Hausberg M, Gremmler B, Liebscher U, Tokmak F, Nguyen MQ, Liebscher H. Klinische Symptome bei Magnesiummangel-Patienten. Nieren- und Hochdruckkrkh. 2008; 37: 597-601.
15. Kosch M, Hausberg M, Westermann G, Köneke J, Matzkies F, Rahn KH, Kisters K. Alterations in calcium and magnesium content of red cell membranes in patients with primary hypertension. Am J Hypertens. 2001; 14: 254-258. doi:10.1016/S0895-7061(00)01271-1 PubMed (Pubitemid 32202709)
16. Laires MJ, Monteiro C. Exercise, magnesium and immune function. Magnes Res. 2008; 21: 92-96. PubMed
17. Porta S, Epple A, Leitner G, Frise E, Liebmann P, Vogel W, Pfeiffer K, Eber O, Buchinger W. Impact of stress and triodothyronine on plasma magnesium fractions. Life Sci. 1994; 55: 327-332. doi:10.1016/0024-3205(94)00772-1 PubMed
18. Rayssiguier Y, Durlach J, Gueux E, Rock E, Mazur A. Magnesium and ageing. I. Experimental data: importance of oxidative damage. Magnes Res. 1993; 6: 369-378. PubMed
19. Resnick LM, Laragh JH, Sealey JE, Alderman MH. Divalent cations in essential hypertension. Relations between serum ionized calcium, magnesium, and plasma renin activity. N Engl J Med. 1983; 309: 888-891. doi:10.1056/ NEJM198310133091504 PubMed (Pubitemid 13014029)
20. Seelig M. The magnesium factor. New York. Penguin Group Inc 2003.
21. Stendig-Lindberg G, Wacker WE, Shapiro Y. Long term effects of peak strenuous effort on serum magnesium, lipids, and blood sugar in apparently healthy young men. Magnes Res. 1991; 4: 59-65. PubMed
22. ++ uptake channels. TRPM6 and TRPM7 in vascular smooth muscle cells from WKY and SHR-differential regulation by aldosterone and angiotension II. Am J Hypertens. 2004; 17: 176. doi:10.1016/j.amjhyper.2004.03.463
23. Dickinson HO, Nicolson DJ, Campbell F, Cook JV, Beyer FR, Ford GA, Mason J. Magnesium supplementation for the management of essential hypertension in adults. Cochrane Database Syst Rev 2206; 19: CD004640.
24. Barbagallo M, Dominguez LJ, Galioto A, Pineo A, Belvedere M. Oral magnesium supplementation improves vascular function in elderly diabetic patients. Magnes Res. 2010; 23: 131-137. PubMed
25. Kisters K. Oral magnesium supplementation improves borderline hypertension. Magnes Res Mar 8, Epub 2011.
26. Kisters K, Tokmak F, Nguyen MQ, Gremmler B, Funke C, Hausberg M. Magnesiumtherapie in borderline hypertension. J Hypertens. 2011; 29: e532.